Vident Advisory LLC Has $248,000 Stock Position in Confluent, Inc. $CFLT

Key Points

• Vident Advisory LLC significantly reduced its holdings in Confluent, Inc. by 69.6%, leaving them with a stock position valued at $248,000.
• Confluent reported a 20.1% increase in quarterly revenue year-over-year, reaching $282.29 million, and beat earnings estimates by $0.01.
• Wall Street analysts have lowered their target prices for Confluent, with a consensus rating of "Moderate Buy" and a price target averaging $27.36.

Vident Advisory LLC trimmed its holdings in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) by 69.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,582 shares of the company's stock after selling 24,179 shares during the period. Vident Advisory LLC's holdings in Confluent were worth $248,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Cloud Capital Management LLC acquired a new position in Confluent during the first quarter valued at $26,000. Versant Capital Management Inc grew its stake in Confluent by 2,458.2% in the first quarter. Versant Capital Management Inc now owns 1,714 shares of the company's stock valued at $40,000 after purchasing an additional 1,647 shares in the last quarter. SVB Wealth LLC purchased a new position in Confluent in the first quarter valued at about $54,000. GAMMA Investing LLC grew its stake in Confluent by 26.8% in the first quarter. GAMMA Investing LLC now owns 3,128 shares of the company's stock valued at $73,000 after purchasing an additional 661 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its stake in Confluent by 39.3% in the first quarter. PNC Financial Services Group Inc. now owns 4,053 shares of the company's stock valued at $95,000 after purchasing an additional 1,143 shares in the last quarter. 78.09% of the stock is owned by institutional investors and hedge funds.

Confluent Price Performance

Shares of NASDAQ:CFLT opened at $19.96 on Wednesday. The business has a 50 day moving average price of $21.27 and a 200 day moving average price of $23.01. Confluent, Inc. has a twelve month low of $15.64 and a twelve month high of $37.90. The company has a market cap of $6.88 billion, a price-to-earnings ratio of -21.23 and a beta of 0.97. The company has a quick ratio of 3.98, a current ratio of 3.98 and a debt-to-equity ratio of 1.03.

Confluent (NASDAQ:CFLT - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.01. Confluent had a negative return on equity of 27.34% and a negative net margin of 29.27%.The firm had revenue of $282.29 million during the quarter, compared to the consensus estimate of $278.32 million. During the same quarter in the prior year, the company earned $0.06 EPS. The firm's revenue for the quarter was up 20.1% compared to the same quarter last year. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. Research analysts predict that Confluent, Inc. will post -0.83 earnings per share for the current year.

Insider Activity at Confluent

In other news, CFO Rohan Sivaram sold 26,097 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $17.01, for a total transaction of $443,909.97. Following the transaction, the chief financial officer owned 636,596 shares in the company, valued at approximately $10,828,497.96. The trade was a 3.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CRO Ban Ryan Norris Mac sold 15,200 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $17.01, for a total transaction of $258,552.00. Following the transaction, the executive owned 397,345 shares in the company, valued at approximately $6,758,838.45. The trade was a 3.68% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 582,421 shares of company stock worth $10,454,916. Insiders own 13.82% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Oppenheimer lowered their target price on Confluent from $32.00 to $26.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Guggenheim lowered their target price on Confluent from $31.00 to $29.00 and set a "buy" rating on the stock in a research note on Thursday, July 31st. DA Davidson lowered their target price on Confluent from $32.00 to $24.00 and set a "buy" rating on the stock in a research note on Thursday, July 31st. Raymond James Financial cut their price target on shares of Confluent from $30.00 to $25.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Finally, Barclays cut their price target on shares of Confluent from $31.00 to $24.00 and set an "overweight" rating on the stock in a report on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $27.36.

Confluent Profile

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.